PROM1 and neoplasm: The tumour BLI showed that the antitumor ability of CD133 CAR-T and PD-1 s cells was stronger than that of Mock T or CD133 CAR-T cells (P = 0.0317 and P = 0.0556, respectively, Fig. 6D–G).